American Society of Hematology

Hematologists from Developing Countries Participate in 2017 ASH Visitor Training Program

(WASHINGTON, September 13, 2017) – The American Society of Hematology (ASH) today announced the names of 25 hematologists and medical professionals from developing countries selected to participate in the 2017 ASH Visitor Training Program (VTP). Participants will receive up to 12 weeks of specialized hematology training at host institutions in many different parts of the world. After the program, participants will return home to implement their newly acquired skills and knowledge to address a specific need, helping to build hematology capacity and expertise at their respective institutions.

“Participants taking part in this program will gain new insights to take home and share with their colleagues, which will ultimately help improve patient care in their countries,” said ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. “The Visitor Training Program is one of several ways ASH is working through training programs and workshops to improve hematology care of patients all over the world .”

This year’s program includes participants from 13 countries who are training at top institutions in North America, Africa, Europe, and Asia. Their areas of study vary from bone marrow transplantation to hematologic malignancies and the management of sickle cell disease. VTP participants will carry out their training in the clinic or laboratory of an ASH member mentor. Additionally, participants will be assigned a counselor from the ASH International Members Committee who will assist them with understanding the rigorous scientific community of ASH and evaluate the progress of both the participant and the host mentor.

The 2017 Visitor Training Participants are:

Participant & Home CountryTraining TopicMentor & Host Institution
Gunay Aliyeva, BS, MSc
Baku, Azerbaijan
Molecular assays in hemoglobinopathy and thalassemia diagnosis Carolyn C. Hoppe, BS, MPH, MD
UCSF Benioff Children’s Hospital
Oakland, CA
Daniela Barbieri
Buenos Aires, Argentina
Next generation sequencing for genetic panels for epigenetic markers and mutational profiling Maria Figueroa, MD
University of Miami Miller School of Medicine
Miami, FL
Livingstone Dogara, MBBS, FMCPath
Kaduna, Nigeria
Coagulation tests for hemophilia, thrombosis, and hemostasis Johnny Mahlangu, MD, BS
Charlotte Maxeke Johannesburg Hospital
Johannesburg, South Africa
Nermeen Eldabah, MBCHB, MSc, MD
Alexandria, Egypt
Cytogenetic analysis for hematological disorders and malignancies George Deeb, MD
Emory University
Atlanta, GA
Tushar Idhate, MD
Jamner, India
Management of sickle cell disease and thalassemia Baba Inusa, MD, MRCP
Guy’s & St. Thomas’ NHS Foundation Trust
London, UK
Raheel Iftikhar, MBBS, FCPS, FACP
Rawalpindi, Pakistan
Allogeneic hematopoietic stem cell transplantation Ghulam J. Mufti, DM, FRCP, FRCPath
King’s College Hospital NHS Foundation Trust
London, UK
Mohammad Islam, MBBS, BCS, FCPS
Dhaka, Bangladesh
Management of allogeneic bone marrow transplantation in transfusion dependent thalassemia patients Vikram Mathews, MD
Christian Medical College
Vellore, India
Olufunto Kalejaiye, MB, ChB, FMCP
Lagos, Nigeria
Morphology and interpretation of immunochemistry, blood film, and bone marrow aspiration slides Alok Srivastava, MD
Christian Medical College
Vellore, India
Oluwatobi Lala, BS
Ibadan, Nigeria  
Cell morphology and staining George Deeb, MD
Emory University
Atlanta, GA
Levani Makhaldiani, MD
Tbilsi, Georgia
Autologous bone marrow transplantation for multiple myeloma Daniel Weisdorf, MD
University of Minnesota
Minneapolis, MN
Anali Mora-Alferez, MD
Lima, Peru
Diagnosis and management of hereditary hematological neoplasia Lucy Godley, MD, PhD
University of Chicago
Chicago, IL
Ogechukwu Obi, BSc, MBBS
Port Harcourt, Nigeria
Management of thrombosis and hemostasis/blood clotting Adam Cuker, MD, MS
University of Pennsylvania
Philadelphia, PA
Veerendra Patil, MD, FNB
Bengaluru, India
Diagnosis and treatment of pediatric primary immunodeficiency disorders Rakesh Goyal, MD, MRCP
Children’s Mercy Hospital
Kansas City, MO
Mauricio Postigo MacDowall, MD
Arequipa, Peru
Peripheral blood/marrow morphology Michael Linden, MD, PhD
University of Minnesota
Minneapolis, MN
Khaliqur Rahman, MBBS, MD
Lucknow, India
Complete laboratory workup of lymphoma   Vishala Neppalli, MD
Roswell Park Cancer Institute
Buffalo, NY
Syed Raza, PhD
Lucknow, India
Molecular genetic testing and diagnosis of acute myeloid leukemia, chronic myeloid leukemia, minimal residual disease, and thalassemia 1 Te-Chih Liu, MBBS, MRCP, FRCPath
National University Hospital
Singapore
Anam Sadiq, PharmD
Rawalpindi, Pakistan
Developing protocols and standard operating procedures for clinical pharmacy practice in hematology, hematology-oncology, and hematopoietic stem cell transplantation Charles Craddock, FRCP, FRCPath
Queen Elizabeth Hospital
Birmingham, UK
Yee Loong Tang, MD, DrPath
Kuala Lumpur, Malaysia
Flow cytometry and clinical data interpretation George Deeb, MD
Emory University
Atlanta, GA
Selami Toprak, MD
Ankara, Turkey
Hematopoietic stem cell transplantation and management of transplant patients Koen Van Besien, MD, PhD
Weill Cornell University
New York City, NY
Christiana Udo, MBBCH
Abuja, Nigeria
Diagnosis and management of bleeding disorders (hemophilia A & B, and von Willebrand disease) Ravindra Sarode, MD
UT Southwestern Medical Center
Dallas, TX
Angela Ugwu, MBBS, FMCPath
Ituku, Nigeria
Creation and management of an efficient hospital-based blood transfusion system Andreas Greinacher, MD
Institut fur Immunologie und Transfusionmedizin
Greifswald, Germany
Dulanie Wijesekara, MBBS
Kadugannawa, Sri Lanka
Allogeneic and autologous SCT donor recruitment, selection, optimization, conditioning and management of associated complications Alessandro Rambaldi, MD
University of Milan
Milan, Italy
Ei Phyo Win, MBBS, MSc
Yangon, Myanmar
Flow cytometry Joseph Khoury, MD
MD Anderson Cancer Center
Houston, TX
Ayman Youssef, MBBCh
Alexandria, Egypt
Bone marrow transplantation Ahmed Galal, MD
Duke Cancer Center
Durham, NC
MD Abdullah Zubayer Khan, MBBS, FCPS
Dhaka, Bangladesh
Allogeneic stem cell transplantation Thomas Spitzer, MD
Massachusetts General Hospital
Boston, MA

 


The American Society of Hematology (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.  

Amanda Szabo, American Society of Hematology
aszabo@hematology.org; 202-552-4914

back to top